Drugs / BG00012 (DMF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01873417 | May → Nov 2013 | multiple sclerosis | Biogen | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG00012 (DMF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01873417 ↗ |